CD44 and neoplasm: Although, dissociated tumor cells from co-treated SKOV3 xenografts significantly reduced the proportion of CD44 population (4.97%) and ALDH (2.05%) activity in these tumors, these proportions remained higher in the controls and monotherapy treated tumors (Fig. 7c).